INDUSTRY COMPONENT

Crystalline Domains

Crystalline domains are structural units within microcrystalline cellulose that determine its pharmaceutical-grade properties and functionality.

View Specifications

Component Specifications

Definition
Crystalline domains refer to the ordered, crystalline regions within microcrystalline cellulose particles that form during controlled hydrolysis and mechanical processing. These domains are responsible for the material's compressibility, flow characteristics, and binding properties in pharmaceutical tablet formulations. The size, distribution, and orientation of these domains directly influence the excipient's performance in drug delivery systems.
Working Principle
Crystalline domains function by providing structural integrity and predictable deformation characteristics under compression. During tablet manufacturing, these domains undergo elastic and plastic deformation, creating interparticulate bonds that maintain tablet integrity while allowing controlled drug release. The crystalline structure provides consistent bulk density and flow properties essential for automated pharmaceutical production.
Materials
Pharmaceutical-grade microcrystalline cellulose (MCC) derived from alpha-cellulose through controlled acid hydrolysis, typically meeting USP/NF, Ph.Eur., and JP specifications. Minimum 99.5% cellulose content with controlled degree of polymerization (DP 150-350).
Technical Parameters
  • Domain Size 10-50 nm
  • Bulk Density 0.25-0.45 g/cm³
  • Tapped Density 0.35-0.55 g/cm³
  • Moisture Content ≤5.0%
  • Crystallinity Index 60-85%
  • pH (10% suspension) 5.0-7.5
  • Particle Size Distribution D50: 50-150 μm
Standards
ISO 9001, ISO 13485, USP <1061>, Ph.Eur. 2.9.36, FDA 21 CFR Part 211

Industry Taxonomies & Aliases

Commonly used trade names and technical identifiers for Crystalline Domains.

crystalline domains microcrystalline cellulose pharmaceutical excipients tablet compression drug formulation MCC properties pharmaceutical manufacturing excipient specifications Crystalline Domains in Chemical Manufacturing

Parent Products

This component is used in the following industrial products

Pharmaceutical-Grade Microcrystalline Cellulose

Purified, partially depolymerized cellulose excipient for pharmaceutical formulations

View Product Details

Engineering Analysis

Risks & Mitigation
  • Inconsistent domain structure leading to batch variability
  • Moisture sensitivity affecting crystalline stability
  • Contamination risk during processing
FMEA Triads
Trigger: Incomplete hydrolysis during manufacturing
Failure: Reduced crystallinity index and poor compression properties
Mitigation: Implement real-time process analytical technology (PAT) monitoring and strict hydrolysis parameter controls
Trigger: Improper drying conditions
Failure: Moisture-induced domain restructuring and reduced flowability
Mitigation: Use controlled humidity drying chambers with validated drying curves and moisture content verification

Industrial Ecosystem

Compatible With

Interchangeable Parts

Compliance & Inspection

Tolerance
±2% crystallinity index variation within batch, ±5% between batches
Test Method
X-ray diffraction (XRD) for crystallinity determination, laser diffraction for particle size, USP <701> for disintegration testing

Procurement Evaluation Criteria

Not customer reviews or live demand data. These dimensions support RFQ preparation and supplier evaluation.

Technical documentation
4/5
Manufacturing capability
4/5
Inspection readiness
5/5
Supplier transparency
3/5

These scores are example evaluation dimensions, not real customer ratings, country-specific buyer feedback, or live inquiry activity.

Related Components

Back Pressure Regulator
A back pressure regulator is a precision valve that maintains constant upstream pressure in continuous flow reactor systems by controlling downstream pressure.
In-line Analyzer Port
In-line analyzer port for real-time chemical composition monitoring in continuous flow reactors
Seeding Port
A precision port for introducing seed crystals into batch crystallization systems to initiate controlled crystal growth.
Sight Glass
A transparent window for visual inspection of fluid flow and crystallization processes in industrial systems.

Frequently Asked Questions

What is the primary function of crystalline domains in pharmaceutical applications?

Crystalline domains provide the structural framework that enables microcrystalline cellulose to function as an effective binder and disintegrant in tablet formulations, ensuring consistent compression behavior and predictable drug release profiles.

How do crystalline domains affect tablet hardness and dissolution?

Optimal crystalline domain structure creates a balance between tablet hardness (through effective bonding during compression) and rapid disintegration (through capillary action and swelling), ensuring both mechanical strength and efficient drug release.

Can I contact factories directly?

Yes, each factory profile provides direct contact information.

Data Basis

CNFX manufacturer profiles, technical classification, publicly available product information, and ongoing plausibility checks.

Preliminary Technical Classification
This page supports structured research, RFQ preparation, and supplier evaluation. It does not replace buyer-led supplier qualification, standards review, or technical approval.

Request Manufacturing Insight for Crystalline Domains

Cross-linking Agents Crystalline Form